Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Taiga Nishihori"'
Autor:
Bhagirathbhai Dholaria, Aleksandar Radujkovic, Noel Estrada‐Merly, Tiarlan Sirait, Soyoung Kim, Juan Carlos Hernández‐Boluda, Tomasz Czerw, Patrick J. Hayden, Ankit Kansagra, Vincent T. Ho, Taiga Nishihori, Paul Shaughnessy, Bart Scott, Ryotaro Nakamura, Betul Oran, Mohamed Kharfan‐Dabaja, Bipin N. Savani, Donal McLornan, Ibrahim Yakoub‐Agha, Wael Saber
Publikováno v:
British Journal of Haematology. 198:785-789
Autor:
Steven G.E. Marsh, Dipenkumar Modi, Yvette L. Kasamon, Shahinaz M. Gadalla, Effie W. Petersdorf, Michelle Kuxhausen, Stephen R. Spellman, Shannon R. McCurdy, Scott R. Solomon, Michael R. Grunwald, Sophie Paczesny, Stephanie Fingerson, Asad Bashey, Ephraim J. Fuchs, Taiga Nishihori, Caroline McKallor, Bronwen E. Shaw, Joseph P. McGuirk, Stephanie J. Lee, Tao Wang, Megan M. Herr, Ayman Saad, Yung-Tsi Bolon
Publikováno v:
Blood
Hematopoietic cell transplantation from HLA-haploidentical related donors is increasingly used to treat hematologic cancers; however, characteristics of the optimal haploidentical donor have not been established. We studied the role of donor HLA mism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4a25019408062418c218e689faacd7a
https://europepmc.org/articles/PMC8914182/
https://europepmc.org/articles/PMC8914182/
Autor:
Guru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, Noel Estrada-Merly, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Sherif M. Badawy, Amer Beitinjaneh, Chris Bredeson, Jean-Yves Cahn, Jan Cerny, Miguel Angel Diaz Perez, Nosha Farhadfar, Robert Peter Gale, Siddhartha Ganguly, Usama Gergis, Gerhard C. Hildebrandt, Michael R. Grunwald, Shahrukh Hashmi, Nasheed M. Hossain, Matt Kalaycio, Rammurti T. Kamble, Mohamed A. Kharfan-Dabaja, Betty Ky Hamilton, Hillard M. Lazarus, Jane Liesveld, Mark Litzow, David I. Marks, Hemant S. Murthy, Sunita Nathan, Aziz Nazha, Taiga Nishihori, Sagar S. Patel, Attaphol Pawarode, David Rizzieri, Bipin Savani, Sachiko Seo, Melhem Solh, Celalettin Ustun, Marjolein van der Poel, Leo F. Verdonck, Ravi Vij, Baldeep Wirk, Betul Oran, Ryotaro Nakamura, Bart Scott, Wael Saber
Publikováno v:
JAMA Oncology, 8(3), 404-411. American Medical Association
JAMA Oncol
JAMA Oncol
Importance Matched sibling donors (MSDs) are preferred for allogeneic hematopoietic cell transplantation (allo-HCT) in myelodysplastic syndrome even if they are older. However, whether older MSDs or younger human leukocyte antigen-matched unrelated d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::639bda17f43fbaee45fe98e0c1f19058
https://cris.maastrichtuniversity.nl/en/publications/7f0ea0f4-e0d2-4f89-b272-9faba5655f2c
https://cris.maastrichtuniversity.nl/en/publications/7f0ea0f4-e0d2-4f89-b272-9faba5655f2c
Autor:
Melhem Solh, Biju George, Mariam H Johnson, Vikas Gupta, Daniel J. Weisdorf, Michael R. Grunwald, Wael Saber, Andrew St. Martin, Minoo Battiwalla, Christopher G. Kanakry, Rohtesh S. Mehta, Mary Eapen, Corey Cutler, Christopher Bredeson, Ryotaro Nakamura, Filippo Milano, Taiga Nishihori, Edward A. Copelan, Asad Bashey, Alberto Mussetti, Hany Elmariah, Mei-Jie Zhang
Publikováno v:
Blood Adv
We compared outcomes in 603 patients with myelodysplastic syndrome (MDS) after HLA-haploidentical relative (n = 176) and HLA-matched unrelated (n = 427) donor hematopoietic cell transplantation (HCT) from 2012 to 2017, using the Center for Internatio
Autor:
Sagar S. Patel, Kwang Woo Ahn, Manoj Khanal, Caitrin Bupp, Mariam Allbee-Johnson, Navneet S. Majhail, Betty K. Hamilton, Seth J. Rotz, Hasan Hashem, Amer Beitinjaneh, Hillard M. Lazarus, Maxwell M. Krem, Tim Prestidge, Neel S. Bhatt, Akshay Sharma, Shahinaz M. Gadalla, Hemant S. Murthy, Larisa Broglie, Taiga Nishihori, César O. Freytes, Gerhard C. Hildebrandt, Usama Gergis, Sachiko Seo, Baldeep Wirk, Marcelo C. Pasquini, Bipin N. Savani, Mohamed L. Sorror, Edward A. Stadtmauer, Saurabh Chhabra
Publikováno v:
Transplant Cell Ther
Noninfectious pulmonary toxicity (NPT), a significant complication of allogeneic hematopoietic cell transplantation (alloHCT), includes idiopathic pneumonia syndrome (IPS), diffuse alveolar hemorrhage (DAH), and cryptogenic organizing pneumonia (COP)
Autor:
Siddhartha Ganguly, Andrew Daly, Tracey A. O'Brien, Melhem Solh, Steven Z. Pavletic, Rammurti T. Kamble, Leslie Lehmann, Tao Wang, Takanori Teshima, Amer Beitinjaneh, Miguel Pérez, Mahmoud Aljurf, Mukta Arora, John L. Wagner, Medhat Askar, Marjolein van der Poel, Madan Jagasia, Rabi Hanna, Alvaro Urbano-Ispizua, Ravi Vij, Armin Rashidi, Taiga Nishihori, Catherine J. Lee, A. Samer Al-Homsi, Vijaya Raj Bhatt, Michael T. Hemmer, Roger Strair, Hannah Choe, Joseph Pidala, Jeffery J. Auletta, Hisham Abdel-Azim, Vaibhav Agrawal, Shahinaz M. Gadalla, Stefan O. Ciurea, S Spellman, Margaret L. MacMillan, Rodrigo Martino, Jean-Yves Cahn, Mitchell S. Cairo, Basem M. William, Rizwan Romee, Jean A. Yared, Navneet S. Majhail, Annie Im, Usama Gergis, Mohamed A. Kharfan-Dabaja, Richard F. Olsson, Sagar S. Patel, Baldeep Wirk, Peiman Hematti, Michael Byrne, Asad Bashey, Hemant S. Murthy, Betty K. Hamilton, Muna Qayed, Pooja Khandelwal, Robert Peter Gale, Saurabh Chhabra, Gerhard C. Hildebrandt, Jan Cerny, Sachiko Seo, Roger H. Herzig, Nosha Farhadfar, Deepesh Lad, Hélène Schoemans, Akshay Sharma, Tim Prestidge, Lazaros J. Lekakis, Daniel J. Weisdorf, Paul Castillo, Miguel-Angel Perales
Publikováno v:
Biol Blood Marrow Transplant
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Biology of Blood and Marrow Transplantation, 26(8), 1459-1468. Elsevier Science
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Biology of Blood and Marrow Transplantation, 26(8), 1459-1468. Elsevier Science
Post-transplant cyclophosphamide (PTCy) has significantly increased the successful use of haploidentical donors with a relatively low incidence of graft-versus-host disease (GVHD). Given its increasing use, we sought to determine risk factors for GVH
Autor:
Michael Byrne, Jane L. Liesveld, Richard F. Olsson, Sagar S. Patel, Hongtao Liu, Eric Wong, Brenda M. Sandmaier, Bipin N. Savani, Hannah Choe, Partow Kebriaei, Gulrayz Ahmed, Tania Jain, Moussab Damlaj, Rebecca L. Olin, Mehdi Hamadani, Uday R. Popat, Neil Palmisiano, Rajneesh Nath, Mei-Jie Zhang, Mark R. Litzow, Attaphol Pawarode, Mark P. Hertzberg, Taiga Nishihori, Arnon Nagler, Jean A. Yared, Mitchell S. Cairo, Ioannis Politikos, Michael R. Grunwald, Hisham Abdel-Azim, Usama Gergis, David A. Rizzieri, Baldeep Wirk, Ashish Bajel, Rammurti T. Kamble, Hemant S. Murthy, Jean-Yves Cahn, Corey Cutler, Mahmoud Aljurf, A. Samer Al-Homsi, Geoffrey L. Uy, Miguel-Angel Perales, Muhammad Waqas Khan, Miguel Angel Diaz, Minocher Battiwalla, Mohamed A. Kharfan-Dabaja, Nosha Farhadfar, Natasha Kekre, Vaibhav Agrawal, Hillard M. Lazarus, Jan Cerny, Rodrigo Martino, Nandita Khera, Youjin Wang, Asmita Mishra, Nasheed Hossain, Luis Isola, Leo F. Verdonck, Nirav N. Shah, Vijaya Raj Bhatt, Zachariah DeFilipp, Daniel J. Weisdorf, Vikram Mathews, Edward A. Copelan, Aaron T. Gerds, C. Esar O. Freytes, David Valc A. Arcel, Shahrukh K. Hashmi, Mrinal M. Patnaik, Sunita Nathan, Sachiko Seo, Marcos de Lima, Qaiser Bashir, David I. Marks, Zheng Zhou, Yoshihiro Inamoto, Ryotaro Nakamura, Hai-Lin Wang, Edmund K. Waller, James M. Foran, Gerhard C. Hildebrandt, Amer Assal, Zartash Gul, Hassan B. Alkhateeb, Ulrike Bacher, Wael Saber
Publikováno v:
Blood Advances
There is a lack of large comparative study on the outcomes of reduced intensity conditioning (RIC) in acute myeloid leukemia (AML) transplantation using fludarabine/busulfan (FB) and fludarabine/melphalan (FM) regimens. Adult AML patients from Center
Autor:
Leona Holmberg, Lori Muffly, Alison W. Loren, Miguel-Angel Perales, Usama Gergis, Tao Wang, Christopher A. Barker, Betty K. Hamilton, Allistair Abraham, Peiman Hematti, Miguel Angel Diaz, Eva C. Guinan, Edward A. Stadtmauer, Sanghee Hong, Jeffery J. Auletta, Gerhard C. Hildebrandt, Marcelo C. Pasquini, Christopher Bredeson, Siddhartha Ganguly, Shin Mineishi, Shahrukh K. Hashmi, Caitrin Fretham, Robert Peter Gale, Hillard M. Lazarus, Jean-Yves Cahn, Kehinde Adekola, Jean A. Yared, Natasha Kekre, Cesar O. Freytes, Saurabh Chhabra, Taiga Nishihori, Rodrigo Martino, Amer Beitinjaneh, Mitchell Sabloff
Publikováno v:
Biol Blood Marrow Transplant
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Malignancy relapse is the most common cause of treatment failure among recipients of hematopoietic cell transplantation (HCT). Conditioning dose intensity can reduce disease relapse but is offset by toxicities. Improvements in radiotherapy techniques
Autor:
Miguel Pérez, Marjolein van der Poel, Vaibhav Agrawal, Mark R. Litzow, Partow Kebriaei, Khalid Bo-Subait, Nelli Bejanyan, John L. Wagner, Aric C. Hall, Jean A. Yared, A. Samer Al-Homsi, Gerhard C. Hildebrandt, Jan Cerny, Mohamed A. Kharfan-Dabaja, Brenda M. Sandmaier, Taiga Nishihori, O Ringdén, Amer Assal, Christopher G. Kanakry, Bipin N. Savani, Leo F. Verdonck, Amer Beitinjaneh, Marcos de Lima, Mitchell S. Cairo, Richard F. Olsson, Mary Lynn Savoie, Hillard M. Lazarus, Michael R. Grunwald, Michael Byrne, Natalie S. Callander, Leland Metheny, Christopher Bredeson, Jong Wook Lee, Sachiko Seo, Christopher S. Hourigan, Ulrike Bacher, Wael Saber, Mei-Jei Zhang, David A. Rizzieri, Vijaya Raj Bhatt, Shahrukh K. Hashmi, Yoshihiro Inamoto, Sunita Nathan, Daniel J. Weisdorf, Zachariah DeFilipp, Cesar O. Freytes, Hai-Lin Wang, Siddhartha Ganguly
Publikováno v:
Transplant Cell Ther
Transplantation and Cellular Therapy, 27(11). Elsevier
Transplantation and Cellular Therapy, 27(11). Elsevier
Patients who develop therapy-related myeloid neoplasm, either myelodysplastic syndrome (t-MDS) or acute myelogenous leukemia (t-AML), have a poor prognosis. An earlier Center for International Blood and Marrow Transplant Research (CIBMTR) analysis of
Autor:
Ronald Sobecks, Melhem Solh, Baldeep Wirk, Joseph P. McGuirk, Zhen-Huan Hu, Kwang Woo Ahn, Yoshihiro Inamoto, Edward Agura, Ulrike Bacher, Miguel-Angel Perales, Usama Gergis, Harry C. Schouten, Joseph Pidala, Amer Beitinjaneh, Amelia Langston, Ran Reshef, Mohamed A. Kharfan-Dabaja, Robert S. Negrin, Saurabh Chhabra, David I. Marks, Virginia O. Volpe, Nilanjan Ghosh, Asad Bashey, Jennifer R. Brown, William J. Hogan, Ayman Saad, Wael Saber, Tamila L. Kindwall-Keller, Minoo Battiwalla, Brian T. Hill, Jan Cerny, Uday R. Popat, Oliver W. Press, Hillard M. Lazarus, Sid Ganguly, Jayesh Mehta, Attaphol Pawarode, Nakhle S. Saba, Taiga Nishihori, Edward A. Copelan, Jean A. Yared, Edwin P. Alyea, Jean-Yves Cahn, Steven M. Devine, Mazyar Shadman, Mahmoud Aljurf, Haesook T. Kim, Mohamed L. Sorror, Michael R. Grunwald, Robert Peter Gale, Richard F. Olsson, Richard A. Nash, Joseph H. Antin, Mehdi Hamadani, Stephen J. Forman, Gregory A. Hale, Bipin N. Savani, Matthew S. Davids, Sunita Nathan, Sergio Giralt, Joseph P. Uberti, Gerhard C. Hildebrandt
Publikováno v:
Clinical Cancer Research, 25(16), 5143-5155. American Association for Cancer Research Inc.
Purpose: To develop a prognostic model and cytogenetic risk classification for previously treated patients with chronic lymphocytic leukemia (CLL) undergoing reduced intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (HCT). Ex